OR WAIT null SECS
September 20, 2018
The biopharmaceutical company will invest approximately $800 million to expand facilities and manufacturing capacity at its campus in Rensselaer County, NY.
September 19, 2018
PCI Pharma Services and CSP Technologies will partner on protective packaging solutions for clinical trials and stability testing.
September 13, 2018
The collaboration will focus on developing manufacturing solutions for biosimilars.
September 10, 2018
The collaboration will explore the potential of Dyadic’s gene-expression platform to produce multiple biologic vaccines and drugs.
September 06, 2018
Novartis will sell selected portions of its Sandoz United States portfolio to Aurobindo Pharma USA for $900 million in cash, plus $100 million in potential earn-outs.
The purchase of Novartis’ cystic fibrosis products TOBI Podhaler and TOBI solution is expected to strengthen Mylan’s global respiratory portfolio.
August 27, 2018
The Coalition for Epidemic Preparedness Innovations (CEPI) and vaccine manufacturer IDT Biologika will collaborate to develop and manufacture a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
August 16, 2018
The companies entered a multi-year R&D collaboration to develop mRNA-based flu vaccines.
August 08, 2018
Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.
August 06, 2018
The companies will collaborate on the discovery, development, and commercialization of cell therapies for cancer.